Supreme Court Lets Stand 2nd Circuit Kickback Ruling In Pfizer Drug Co-Pay Case
WASHINGTON, D.C. — The U.S. Supreme Court has denied a petition by drugmaker Pfizer Inc. to review a federal appeals court ruling that a patient assistance program for a $225,000-a-year heart...To view the full article, register now.
Already a subscriber? Click here to view full article